Encouraging moderate physical activity is recommended for patients with colon cancer. The combination of raltitrexed and oxaliplatin may be considered for patients with cardiac toxicity or DPD deficiency. Clinical trials are ongoing to evaluate adjuvant chemotherapy and aspirin in colon cancer patients with specific mutations.